🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Enterobacteriaceae Infections

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants NCT07286370Phase 21 site📍 Banjul GlaxoSmithKline · Tests: Low dose of iNTS-TCV, Full dose of iNTS-TCV, TYPHIBEV, Prevenar 13, Nimenrix Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia. NCT07086391n/a1 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Polymyxin B Sulfate 25mg Jet Nebulization / Vibrating Mesh Nebulization A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) NCT05488340Phase 217 sites📍 Fresno📍 Lancaster📍 Los Angeles Locus Biosciences · Tests: LBP-EC01 0.1 x IV dose, LBP-EC01 0.01x IV Dose, LBP-EC01 IV Infusion Dose, Placebo, LBP-EC01 Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children NCT03825874n/a20 sites📍 Charenton-le-Pont📍 Chennevières-sur-Marne📍 Combs-la-Ville Centre Hospitalier Intercommunal Creteil · Tests: Amikacin, usual antibiotic treatment Study of E. Coli Isolates From Recurrent Urinary Tract Infections NCT05826067n/a1 site📍 Brussels Université Catholique de Louvain · Tests: collection of bacterial strains Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old NCT07049159Phase 21 site📍 Baltimore Eveliqure Biotechnologies GmbH · Tests: ShigETEC vaccine, Placebo, Challenge: Shigella flexneri 2457T at a dose of 1.5x10^3 CFU Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria NCT06910878n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora NCT05153824n/a2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria NCT05017766n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: analysis of antimicrobial resistance Epidemiology and Overtime Genomic Evolution of Klebsiella Pneumoniae and Enterobacter Cloacae Complex (ECC) in Stools of ICU's Patients NCT07744321n/a1 site📍 Caen University Hospital, Caen Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection NCT05219110NA26 sites📍 Birmingham📍 Little Rock📍 La Jolla University of Calgary · Tests: Infusion of 200% maintenance fluids as balanced crystalloid IV solution, Oral fluids; infusion of up to 110% maintenanc… Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria NCT06559618Phase 12 sites📍 St Louis📍 Houston Barbara Trautner · Tests: Phage Therapy, Placebo PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) NCT03671967Phase 414 sites📍 Calgary📍 Surrey📍 St. John's Rambam Health Care Campus · Tests: Piperacillin/tazobactam, Meropenem FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae NCT04759001Phase 1, Phase 21 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Donor FMT, Placebo FMT Transcriptomic Responses for the Identification of Pathogens NCT04878549n/a1 site📍 Vellore University of Sheffield · Tests: 5-gene transcription signature A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age NCT06702449Phase 1, Phase 28 sites📍 Lenexa📍 Secaucus📍 Rochester GlaxoSmithKline · Tests: Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine mediu… Blood Donor CVD 5000 NCT03971669Phase 41 site📍 Baltimore University of Maryland, Baltimore · Tests: Vivotif Typhoid Oral Vaccine Safety and Efficacy of Fecal Microbiota Transplantation NCT04014413NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Fecal Microbiota Transplantation Aztreonam-Avibactam in Immunocompromised Hosts NCT07890480n/a1 site📍 Buenos Aires Centro de Educación Medica e Investigaciones Clínicas Norbe… · Tests: Aztreonam-Avibactam, Ceftazidime-Avibactam Plus Aztreonam Shigella Sonnei 53G Human Infection Study in Kenyan Adults NCT05959616Phase 11 site📍 Kilifi University of Oxford · Tests: Shigella sonnei 53G, Ciprofloxacin 500 mg Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care NCT07236944Phase 413 sites📍 Haukeland📍 Oslo📍 Borås Uppsala University · Tests: Pivmecillinam, Standard of Care (Investigator Choice) A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults NCT07663032Phase 11 site📍 Bloemfontein GlaxoSmithKline · Tests: Pan-Salmonella-with-Alum (Low dose) vaccine, Pan-Salmonella-with-Alum (Full dose) vaccine, Pan-Salmonella-without-Alum … International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections NCT06634940n/a1 site📍 Buenos Aires Hospital Italiano de Buenos Aires Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals NCT05871476NA1 site📍 Thái Bình Hanoi University of Public Health · Tests: Hospital Cohort Care Intervention at the hospital, , Household Education Communication Hygiene Intervention, Livestock … Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial NCT06080698NA11 sites📍 San Francisco📍 Denver📍 Baltimore Johns Hopkins University · Tests: Intravenous Antibiotics, Oral Antibiotics Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children NCT04535661n/a1 site📍 Shanghai Children's Hospital of Fudan University InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia NCT05961059Phase 11 site📍 Leiden Leiden University Medical Center · Tests: 2.5 μg InvaplexAR-Detox, 10 μg InvaplexAR-Detox, 0.1 μg of dmLT, Placebo Cefotetan Therapy for Escherichia Coli Infections NCT07318584Phase 21 site📍 Portland Oregon Health and Science University · Tests: Cefotetan, Carbapenems, Beta Lactam Antibiotics The Impact of Shigellosis and Recommended Treatment in Children NCT07433426Phase 24 sites📍 Chāndpur📍 Dhaka📍 Lusaka Johns Hopkins Bloomberg School of Public Health · Tests: Azithromycin, Placebo Transmission of ESBL-producing Enterobacteriaceae NCT03465683n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: ESBL-producing Enterobacteriaceae
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy